학술논문

Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates
Document Type
Article
Source
In Vaccine 20 January 2016 34(4):523-530
Subject
Language
ISSN
0264-410X